9-121975-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018491.5(ZNG1A):c.1067G>A(p.Arg356Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000274 in 1,611,718 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00028 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00027 ( 0 hom. )
Consequence
ZNG1A
NM_018491.5 missense
NM_018491.5 missense
Scores
4
15
Clinical Significance
Conservation
PhyloP100: 5.20
Genes affected
ZNG1A (HGNC:17134): (Zn regulated GTPase metalloprotein activator 1A) Predicted to enable ATP binding activity. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.060367107).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNG1A | NM_018491.5 | c.1067G>A | p.Arg356Gln | missense_variant | 14/15 | ENST00000356521.9 | NP_060961.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNG1A | ENST00000356521.9 | c.1067G>A | p.Arg356Gln | missense_variant | 14/15 | 1 | NM_018491.5 | ENSP00000348915.4 | ||
ZNG1A | ENST00000465014.6 | n.*665G>A | non_coding_transcript_exon_variant | 14/15 | 2 | ENSP00000482298.1 | ||||
ZNG1A | ENST00000612045.4 | n.*788G>A | non_coding_transcript_exon_variant | 15/16 | 1 | ENSP00000477749.1 | ||||
ZNG1A | ENST00000619157.4 | n.*612G>A | non_coding_transcript_exon_variant | 11/12 | 5 | ENSP00000483746.1 | ||||
ZNG1A | ENST00000465014.6 | n.*665G>A | 3_prime_UTR_variant | 14/15 | 2 | ENSP00000482298.1 | ||||
ZNG1A | ENST00000612045.4 | n.*788G>A | 3_prime_UTR_variant | 15/16 | 1 | ENSP00000477749.1 | ||||
ZNG1A | ENST00000619157.4 | n.*612G>A | 3_prime_UTR_variant | 11/12 | 5 | ENSP00000483746.1 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152156Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
42
AN:
152156
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000283 AC: 56AN: 197934Hom.: 0 AF XY: 0.000281 AC XY: 30AN XY: 106892
GnomAD3 exomes
AF:
AC:
56
AN:
197934
Hom.:
AF XY:
AC XY:
30
AN XY:
106892
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000273 AC: 399AN: 1459562Hom.: 0 Cov.: 31 AF XY: 0.000259 AC XY: 188AN XY: 726086
GnomAD4 exome
AF:
AC:
399
AN:
1459562
Hom.:
Cov.:
31
AF XY:
AC XY:
188
AN XY:
726086
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000276 AC: 42AN: 152156Hom.: 0 Cov.: 30 AF XY: 0.000256 AC XY: 19AN XY: 74342
GnomAD4 genome
AF:
AC:
42
AN:
152156
Hom.:
Cov.:
30
AF XY:
AC XY:
19
AN XY:
74342
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
27
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2023 | The c.1067G>A (p.R356Q) alteration is located in exon 14 (coding exon 14) of the CBWD1 gene. This alteration results from a G to A substitution at nucleotide position 1067, causing the arginine (R) at amino acid position 356 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.;.;.
PrimateAI
Benign
T
PROVEAN
Benign
N;.;N;.;N
REVEL
Benign
Sift
Benign
T;.;T;.;T
Sift4G
Uncertain
T;T;T;T;T
Polyphen
P;P;P;.;P
Vest4
MVP
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at